Vieworks Co. Ltd (100120)
KOSDAQ · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 27,750.00 |
|---|---|
| 52-week range | 18,010.00 – 34,900.00 |
| Return, 1 month / 3 months | +7.4% / +19.6% |
| Return, 1 year / 3 years | +43.2% / +2.0% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 61.6% |
| Worst drawdown (1 year) | -38.8% |
| Average daily value traded | 672.77M KRW |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vieworks is a South Korean maker of imaging equipment, based in Anyang. It designs and builds industrial cameras and vision systems used for automated inspection and measurement in manufacturing, along with digital radiography detectors for medical and veterinary imaging. Its customers are machine builders, factory automation integrators, healthcare equipment makers and imaging specialists who need reliable image capture hardware. The company develops its own sensors, electronics and software to support these camera and detector products.
Vieworks Co. Ltd trades under the code 100120 on the KOSDAQ in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vieworks Co. Ltd (100120) trades on the KOSDAQ in Korea. It last closed at KRW 27,750.00 on 23 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 77 of 1,832 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 43.2% and over the last three months it rose 19.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.6% | ||
| From 52-week high | -15.8% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 19.6% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 33.4% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 61.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.8% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 672.77M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.0% |
|---|---|
| 1 month | +7.4% |
| 3 months | +19.6% |
| 6 months | +0.0% |
| 1 year | +43.2% |
| 3 years | +2.0% |
| 5 years | −25.4% |
Signals
| 50-day / 200-day average | 27,415.00 / 25,789.80 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,235.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 690.0000 |
| 27 Dec 2024 | KRW 600.0000 |
| 27 Dec 2023 | KRW 350.0000 |
| 28 Dec 2022 | KRW 700.0000 |
| 29 Dec 2021 | KRW 750.0000 |
| 29 Dec 2020 | KRW 450.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.